← Leaderboards
Paul M. Ridker
Brigham And Women'S Hospital
$62,821,752
Attributed
$65,768,976
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $17.5M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$65,768,976 · 6
By mechanism
U01$55,416,022 · 1
T32$4,977,884 · 1
R01$3,084,784 · 3
UG3$2,290,286 · 1
Top collaborators
- Julie E Buring10 shared
- Jean Marie Connors1 shared
- Alok A Khorana1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Samia Mora$13,080,456
- Robert J Glynn$12,512,252
- Gail Kurr Adler$16,472,973
- Peter Libby$39,585,619
- Elliot Israel$35,880,602
Others in their field
Top investigators on “Epidemiology”
- David Heimbrook · Leidos Biomedical Research, Inc.$390,770,069
- George R Seage · Abt Associates, Inc.$299,251,523
- Jeffrey P Krischer · University Of South Florida$264,076,260
- Barbara Driver · Westat, Inc.$221,167,491
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,739,528
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
EpidemiologyTraining ProgramsMyocardial InfarctionInflammationThrombosisClinical ResearchVenous ThrombosisBiomarkerHuman SubjectRandomizedPlacebo ControlPathway InteractionsPlacebosPulmonary EmbolismRandomized TrialMalignant NeoplasmsInfectionDeep Vein ThrombosisEventEnrollmentInnovationLipidsCessation Of LifeBase
Grant awards (34)
(1/2) Statins to Prevent Cancer Associated Venous Thromboembolism (STAT-CAT): CCC$2,290,286
UG3 · FY2025 · HL · contact PI
Training Program in the Epidemiology of CVD$165,797
T32 · FY2019 · HL · contact PI
Cardiovascular Inflammation Reduction Trial (CIRT)$3,938,519
U01 · FY2018 · HL · contact PI
Training Program in the Epidemiology of CVD$361,210
T32 · FY2018 · HL · contact PI
Cardiovascular Inflammation Reduction Trial (CIRT)$13,389,760
U01 · FY2017 · HL · contact PI
Training Program in the Epidemiology of CVD$344,906
T32 · FY2017 · HL · contact PI
Cardiovascular Inflammation Reduction Trial (CIRT)$11,048,538
U01 · FY2016 · HL · contact PI
Training Program in the Epidemiology of CVD$356,136
T32 · FY2016 · HL · contact PI
Training Program in the Epidemiology of CVD$347,298
T32 · FY2015 · HL · contact PI
Training Program in the Epidemiology of CVD$229,680
T32 · FY2014 · HL · contact PI
Cardiovascular Inflammation Reduction Trial (CIRT)$17,202,355
U01 · FY2013 · HL · contact PI
Training Program in the Epidemiology of CVD$298,892
T32 · FY2013 · HL · contact PI
Cardiovascular Inflammation Reduction Trial (CIRT)$8,957,197
U01 · FY2012 · HL · contact PI
Training Program in the Epidemiology of CVD$167,326
T32 · FY2012 · HL · contact PI
Cardiovascular Inflammation Reduction Trial (CIRT)$879,653
U01 · FY2011 · HL · contact PI
Training Program in the Epidemiology of CVD$294,842
T32 · FY2011 · HL · contact PI
Training Program in the Epidemiology of CVD$274,646
T32 · FY2010 · HL · contact PI
Training Program in the Epidemiology of CVD$153,048
T32 · FY2009 · HL · contact PI
Training Program in the Epidemiology of CVD$295,272
T32 · FY2008 · HL · contact PI
Training Program in the Epidemiology of CVD$267,476
T32 · FY2007 · HL · contact PI
Training Program in the Epidemiology of CVD$226,792
T32 · FY2006 · HL · contact PI
Training Program in the Epidemiology of CVD$242,206
T32 · FY2005 · HL
Training Program Epidemiology of Cardiovascular Disease$267,100
T32 · FY2004 · HL
TRAINING PROGRAM EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE$109,959
T32 · FY2003 · HL
SECONDARY PREVENTION TRIAL OF VENOUS THROMBOSIS$942,900
R01 · FY2002 · HL
THROMBOTIC, INFLAMMATORY &GENE MARKERS OF CVD IN WOMEN$481,007
R01 · FY2002 · HL
TRAINING PROGRAM EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE$202,644
T32 · FY2002 · HL
THROMBOTIC, INFLAMMATORY &GENE MARKERS OF CVD IN WOMEN$463,998
R01 · FY2001 · HL
SECONDARY PREVENTION TRIAL OF VENOUS THROMBOSIS$296,911
R01 · FY2001 · HL
TRAINING PROGRAM EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE$192,980
T32 · FY2001 · HL
THROMBOTIC, INFLAMMATORY &GENE MARKERS OF CVD IN WOMEN$444,174
R01 · FY2000 · HL
SECONDARY PREVENTION TRIAL OF VENOUS THROMBOSIS$281,954
R01 · FY2000 · HL
TRAINING PROGRAM EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE$179,674
T32 · FY2000 · HL
INFLAMMATION, INFECTION AND FUTURE CARDIOVASCULAR RISK$173,840
R01 · FY2000 · HL